127 related articles for article (PubMed ID: 21799610)
1. Understanding non-compliance with WHO-multidrug therapy among leprosy patients in Assam, India.
Kar S; Pal R; Bharati DR
J Neurosci Rural Pract; 2010 Jan; 1(1):9-13. PubMed ID: 21799610
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of factors for interruption of antitubercular treatment among defaulters in urban and rural areas of Kamrup District, Assam.
Ahmed M; Mohan R
J Family Med Prim Care; 2021 Jan; 10(1):127-131. PubMed ID: 34017714
[TBL] [Abstract][Full Text] [Related]
3. Profile of Defaulters and Pattern of Treatment Default among Leprosy Patients at a Tertiary Care Hospital: A 10-Year Analysis.
Mushtaq S; Dogra D; Faizi N; Dogra N
Indian Dermatol Online J; 2020; 11(3):355-360. PubMed ID: 32695693
[TBL] [Abstract][Full Text] [Related]
4. A study on non-adherence to MDT among leprosy patients.
Rao PS
Indian J Lepr; 2008; 80(2):149-54. PubMed ID: 19425509
[TBL] [Abstract][Full Text] [Related]
5. WHO multidrug therapy for leprosy: epidemiology of default in treatment in Agra district, Uttar Pradesh, India.
Kumar A; Girdhar A; Chakma JK; Girdhar BK
Biomed Res Int; 2015; 2015():705804. PubMed ID: 25705679
[TBL] [Abstract][Full Text] [Related]
6. Defaulting patterns in a provincial leprosy control programme in Northern Mozambique.
Griffiths S; Ready N
Lepr Rev; 2001 Jun; 72(2):199-205. PubMed ID: 11495451
[TBL] [Abstract][Full Text] [Related]
7. Interruption and defaulting of multidrug therapy against leprosy: population-based study in Brazil's Savannah Region.
Heukelbach J; André Chichava O; de Oliveira AR; Häfner K; Walther F; de Alencar CH; Ramos AN; Ferreira AC; Ariza L
PLoS Negl Trop Dis; 2011 May; 5(5):e1031. PubMed ID: 21572523
[TBL] [Abstract][Full Text] [Related]
8. Correlates of Defaulting from MDT among Leprosy Patients.
Raju MS; Elkana M; Failbus P; Palla JP; Hembrom UK; Rao PS
Indian J Lepr; 2016 Sep; 87(4):241-248. PubMed ID: 29762953
[TBL] [Abstract][Full Text] [Related]
9. Defaulters among lung cancer patients in a suburban district in a developing country.
Ng TH; How SH; Kuan YC; Fauzi AR
Ann Thorac Med; 2012 Jan; 7(1):12-5. PubMed ID: 22347344
[TBL] [Abstract][Full Text] [Related]
10. Noncompliance with the world health organization-multidrug therapy among leprosy patients in Cebu, Philippines: its causes and implications on the leprosy control program.
Honrado ER; Tallo V; Balis AC; Chan GP; Cho SN
Dermatol Clin; 2008 Apr; 26(2):221-9, vi. PubMed ID: 18346553
[TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial to compare cure and relapse rate of paucibacillary multidrug therapy with monthly rifampicin, ofloxacin, and minocycline among paucibacillary leprosy patients in Agra District, India.
Kumar A; Girdhar A; Girdhar BK
Indian J Dermatol Venereol Leprol; 2015; 81(4):356-62. PubMed ID: 26144850
[TBL] [Abstract][Full Text] [Related]
12. Gender differences in epidemiological factors associated with treatment completion status of leprosy patients in the most hyperendemic district of Nepal.
Kumar RB; Singhasivanon P; Sherchand JB; Mahaisavariya P; Kaewkungwal J; Peerapakorn S; Mahotarn K
Southeast Asian J Trop Med Public Health; 2004 Jun; 35(2):334-9. PubMed ID: 15691132
[TBL] [Abstract][Full Text] [Related]
13. Assessing and improving adherence with multidrug therapy.
Weiand D; Thoulass J; Smith WC
Lepr Rev; 2012 Sep; 83(3):282-91. PubMed ID: 23356029
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological shift in leprosy in a rural district of central India following introduction of multi-drug therapy (April 1986 to March 1992 and April 1992 to March 2002).
Pandey A; Uddin MJ; Patel R
Lepr Rev; 2005 Jun; 76(2):112-8. PubMed ID: 16038244
[TBL] [Abstract][Full Text] [Related]
15. True status of smear-positive pulmonary tuberculosis defaulters in Malawi.
Kruyt ML; Kruyt ND; Boeree MJ; Harries AD; Salaniponi FM; van Noord PA
Bull World Health Organ; 1999; 77(5):386-91. PubMed ID: 10361755
[TBL] [Abstract][Full Text] [Related]
16. Alternate Anti-Leprosy Regimen for Multidrug Therapy Refractory Leprosy: A Retrospective Study from a Tertiary Care Center in North India.
Narang T; Bishnoi A; Dogra S; Saikia UN; Kavita
Am J Trop Med Hyg; 2019 Jan; 100(1):24-30. PubMed ID: 30298809
[TBL] [Abstract][Full Text] [Related]
17. Current Knowledge Attitudes, and Practices of Healthcare Providers about Leprosy in Assam, India.
Kar S; Ahmad S; Pal R
J Glob Infect Dis; 2010 Sep; 2(3):212-5. PubMed ID: 20927279
[TBL] [Abstract][Full Text] [Related]
18. Impact of multidrug therapy on leprosy in Baroda district (Gujarat).
Chopra NK; Agarwal JS; Pandya PG
Indian J Lepr; 1989 Apr; 61(2):179-89. PubMed ID: 2746026
[TBL] [Abstract][Full Text] [Related]
19. Experience with WHO-recommended multidrug therapy (MDT) for multibacillary (MB) leprosy patients in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center in Ethiopia: appraisal of the recommended duration of MDT for MB patients.
Becx-Bleumink M
Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):558-68. PubMed ID: 1802938
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors associated with defaulting from visceral leishmaniasis treatment: analysis under routine programme conditions in Bihar, India.
Kansal S; Chakravarty J; Kumar A; Malaviya P; Boelaert M; Hasker E; Ostyn B; Sundar S
Trop Med Int Health; 2017 Aug; 22(8):1037-1042. PubMed ID: 28594453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
